Sensei Biotherapeutics amends certificate to increase authorized shares

Sensei Biotherapeutics increased authorized Common Stock from an undisclosed prior amount to 300 million shares and authorized Preferred Stock at 10 million shares, totaling 310 million authorized shares. The amendment provides capital structure flexibility for potential financing, acquisitions, or equity-based compensation activities.